Dr. Schnipper was a panelist for the Forum’s discussion on Drug Pricing.
Lowell E. Schnipper, MD, is an internationally renowned leader in hematology-oncology at Beth Israel Deaconess Medical Center Cancer Center. He chaired the American Society of Clinical Oncology’s Value in Cancer Care Task Force.
He is also the Theodore and Evelyn Berenson Professor of Medicine at Harvard Medical School. His personal research interests and contributions have been in the fields of anti-viral and anti-neoplastic drug development, genomic instability of cancer, and clinical investigations into novel cancer therapies.
His leadership has spawned the development of 65 clinicians and scientists who have built nationally prominent programs in molecular imaging aimed at identifying cancer at its most minimal stage, understanding the origins of leukemia, and translational research in tumor vaccines, melanoma, kidney and prostate cancer.
Schnipper earned his medical degree from Downstate College of Medicine and the State University of New York, summa cum laude, and his BA from Queens College in New York. Among his professional and academic associations, he is Associate Director for Membership and Deputy Associate Director for Clinical Services for the Dana-Farber Harvard Cancer Center (DFHCC); has been a member of the national board of directors of the American Cancer Society and president of its Massachusetts division.
Schnipper is the recipient of the St. George Medal from the American Cancer Society, its highest award given to a volunteer, and the Distinguished Public Service Award from the American Society of Clinical Oncology. He has had, and currently holds leadership positions in the American Society of Clinical Oncology. Lowell has been repeatedly named a “Best Doctor” by Boston Magazine, and is listed in “Best Doctors in America.”